Introduction {#s1}
============

*Neisseria meningitidis* (also known as meningococcus) is primarily a human pathogen, which causes meningitis and fatal sepsis. It is normally a commensal in \~10% of the population (Greenfield et al., [@B11]). *N. meningitidis* colonizes the nasopharynx and can subsequently disseminate into the bloodstream allowing contact with the cells of neurovascular unit, which in turn facilitates translocation of bacteria across the blood-brain barrier (BBB) (Lambotin et al., [@B24]).

Human BBB tissue is composed of microvascular endothelial cells (hBMECs), pericytes, astrocytes and the basal lamina (Banks, [@B1]). This structure not only provides protection of the central nervous system (CNS) from microorganisms and toxins but also maintains the brain homeostasis and permits communication between blood and CNS (Banks, [@B1]). Despite highly sophisticated structure of BBB, some pathogens cross the BBB and invade CNS tissue (Doran et al., [@B9]).

The interactions between pathogen ligands and receptors on the cells of neurovascular unit initiate various cell signaling events, which may help pathogen to cross BBB. It has been reported that the type IV pili of *N. meningitidis* activate a β2-adrenergic receptor, which leads to the formation of cortical plaques and provides multiple signaling functions that promote bacterial infection (Miller et al., [@B26]). Opa and Opc surface proteins, located under the polysaccharide capsule, also bind to the endothelial cell receptors (Hardy et al., [@B12]). However, detailed picture of the ligand-receptor interactors that may take part in the translocation of *N. meningitidis* is still incomplete, which indicates a need of a high-throughput approach to reveal plausible meningococcal interactome.

The study of surface proteins containing highly hydrophobic moieties (e.g., membrane proteins) had been hampered by lack of appropriate technology. Gel-based techniques have been applied for the identification of bacterial membrane proteins as well as their receptors (Pulzova et al., [@B36]; Bencurova et al., [@B2]; Mlynarcik et al., [@B27]), however, these techniques are time-consuming and low-throughput. Moreover, gel-based techniques require a higher amount of biological material, which is an inconvenience in studies where the biological material is scarce (e.g., primary cells of the neurovascular unit). So far, high-throughput genomic approaches have been used to identify genes encoding proteins involved in pathogenicity of *N. meningitidis* (Tettelin et al., [@B39]; Zhang et al., [@B52]). This is first study that uses high-throughput mass-spectrometry (MS) to reveal the interactome of N. meningitidis with hBMECs. To identify plausible meningococcal interactome, techniques like labeling of the meningococcal proteome, high-throughput SWATH-MS and bioinformatic pipeline were used here.

Data generated from high-throughput technology requires rigorous data analysis approach to expose relevant biological information and shortlist important gene or protein candidates from large data subset. Bioinformatic analysis applied to a large set of data can help to improve selection of target molecules that are most relevant to the study. We have recently applied a set of bioinformatic tools to select pneumococcal surface proteins that may interact with hBMECs (Jimenez-Munguia et al., [@B18]). Similar bioinformatic pipeline was set in this study using freely available bioinformatic tools (such as CELLO, Psortb, SignalP, LipoP, HMMtop and TMHMM) to identify bacterial proteins that have less chance to bind host cells (e.g., cytoplasmic proteins) and select interacting proteins (plausible interactome).

In this research, by combining proteome labeling (biotinylation), SWATH-MS and performing bioinformatic analysis we attempted to identify ligands of *N. meningitidis* that may have potential to interact with hBMECs. Bioinformatic analysis was used to select five proteins candidates, which were then expressed in *E. coli* and subsequently shown to interact with hBMECs. Using this approach 41 meningococcal proteins that may interact with hBMECs were detected. We were able to validate interactions of selected bacterial ligands with hBMECs, which may play an important role in adherence.

Results presented in this publication together with our recently published study (Jimenez-Munguia et al., [@B18]), validate the experimental and bioinformatic approach designed to uncover potential bacterial ligands interacting with the host cells.

Materials and methods {#s2}
=====================

*N. meningitidis* culture
-------------------------

*N. meningitidis* (isolate M1/03) was grown on Thayer Martin agar and a single isolated colony was transferred into 50 mL of Brain Heart Infusion Broth (BHI) enriched with 10 mM MgCl~2~. Bacterial culture were grown at 37°C and 5% CO~2~ until OD~600~ = 0.6 (mid-exponential phase). The neuroinvasive *N. meningitidis* isolate used in this study was kindly provided by the University Hospital Olomouc, Czech Republic. Phenotypic characterization (biochemical tests) and genotyping (multilocus sequence typing) was performed in the hospital laboratory.

Isolation of proteins of meningococci and biotin labeling
---------------------------------------------------------

Proteins of *N. meningitidis* were extracted exactly as described before (Jimenez-Munguia et al., [@B18]) in non-denaturating lysis buffer containing 20 mM CHAPS, 300 mM NaCl, 0.01% sodium azide and 1 × proteases inhibitors, and biotinylated with EZ-Link Sulfo-NHS-LC-Biotin (Thermo Fisher Scientific) as per manufacturer\'s instructions. Biotinylation was confirmed with NeutrAvidin (Thermo Fisher Scientific) capture followed by SDS-PAGE as per manufacturer\'s instructions. Protein samples were quantified with the Bradford method, aliquoted and stored at −80°C until incubation with hBMECs.

Human brain microvascular endothelial cell culture
--------------------------------------------------

Human BMECs (D3 cell line), were cultured as previously described (Jimenez-Munguia et al., [@B18]). Cells were either incubated with biotinylated proteins of *N. meningitidis* or scrapped for protein isolation.

Isolation of proteins from hBMECs
---------------------------------

Human BMECs were washed twice with EBM-2 medium (without any supplement) and once with phosphate buffer saline (pH 7.2) to remove albumin. Cells were scraped and resuspended in 1 mL of lysis solution (20 mM CHAPS, 300 mM NaCl, 0.1% sodium azide and 1 × proteases inhibitors). Proteins were extracted as previously described (Jimenez-Munguia et al., [@B18]) and stored in aliquots at −80°C until use.

The interaction between biotinylated proteins of *N. meningitidis* and hBMECs
-----------------------------------------------------------------------------

The interaction was performed by incubating 200 μg of biotinylated proteins with confluent hBMECs in 25-mL cell culture flask for 1 h at 37°C in 5% of CO~2~. Cells were washed four times with Dulbecco\'s-PBS (Sigma) to remove unbound biotinylated proteins. The cell monolayer was then scraped in 2 mL PBS. Cells were centrifuged (3,000 × g, 10 min) and supernatant (S1) was kept on ice until use (please note that S1 may contain biotinylated proteins). The cell pellet was resuspended in 200 μL of lysis solution (cell surface protein isolation kit, Thermo Fisher Scientific) followed by 30 min incubation on ice (every 5 min cells were mixed well by 5 s of vortexing). Supernatant S1 was added to the cells in the lysis solution and five cycles of sonication (100% amplitude, 30 s on ice) were carried out. Proteins-containing supernatant (S2) was collected by centrifugation (10,000 × g, 5 min, 4°C). S2 was kept on ice until the capture of biotinylated proteins.

Presence of the biotinylated proteins in S2 was confirmed by dot blot as described earlier (Jimenez-Munguia et al., [@B18]).

Capture of biotinylated proteins from the cell extract (S2) and protein identification
--------------------------------------------------------------------------------------

Biotinylated proteins were captured on NeutrAvidin agarose beads (Thermo Fisher Scientific) according to the manufacturer\'s instructions. In short, NeutrAvidin agarose beads were washed with PBS and incubated with 200 μL of S2 for 1 h. After five wash steps with PBS, biotinylated proteins were eluted in 400 μL of 50 mM dithiothreitol (DTT) in PBS (pH 7.2). Proteins in eluate were identified by mass spectrometry as described in our previous report (Jimenez-Munguia et al., [@B18]).

Bioinformatic pipeline: a systematic selection of potential candidates for validation of interaction with hBMECs
----------------------------------------------------------------------------------------------------------------

We focused mainly on the cell wall proteins. First, subcellular location was assigned to remove proteins with less probability of interaction (intracellular proteins) and shortlist the surface exposed proteins. Second, surface interactome was classified into three categories according to the probability of interaction with host cells based on subcellular location. Third, ontology annotations were retrieved for surface-exposed proteins (Figure [1](#F1){ref-type="fig"}).

![Schematic representation of experimental and bioinformatic workflow performed in this study. Proteins of *N. meningitidis* were isolated^1^ and biotinylated^2^. Biotinylated proteome was incubated with human brain microvascular endothelial cells (hBMECs)^3A^. Unbound proteins were washed off^3Band3C^ and interacting proteins bound to hBMECs were recovered from cell lyste^3D^ with NeutrAvidin capture beads^4aand4b^, eluted with 50 mM DTT^4c^ and identified by SWATH-MS^5^. Combination of bioinformatic tools was used for analyzing the interactome of *N. meningitidis*^6^. Surface proteins were grouped for selection of potential ligands. First analysis^6−I^ (Psortb and Cello) segregated proteins according to subcellular location and intracellular proteins were removed. With the second set of analytic tools^6−II^, interactome was classified into the outer (group 1), inner (group 2) and secretory (group 3) proteins by applying algorithms to predict transmembrane helices (TMHMM and HMMtop) and type I and II signal peptides (SignalP and LipoP). Gene ontology (Blast2GO), UniProt and literature review^6−III^ were performed further on proteins grouped above in 6-II. Bioinformatic pipeline enabled us to select most probable protein candidates that may interact with hBMECs and contribute in pathogenesis^7^. Those protein candidates were overexpressed in *E.coli*^8^ and used for validation with ELISA and immunocytochemistry^9^.](fmicb-09-02294-g0001){#F1}

Primary predictions of subcellular location were assigned with freely available algorithms Psortb (<http://www.psort.org/psortb/>; Yu et al., [@B51]), and Cello (<http://cello.life.nctu.edu.tw/>; Yu et al., [@B50]). Presence of transmembrane domains was evaluated by TMHMM 2.0 (<http://www.cbs.dtu.dk/services/TMHMM-2.0>; Krogh et al., [@B22]) and HMMTOP (<http://www.enzim.hu/hmmtop/>; Tusnady and Simon, [@B42]). Presence of type-I and type-II signal peptides were predicted with SignalP (<http://www.cbs.dtu.dk/services/SignalP-4.0/>; Petersen et al., [@B32]) and LipoP (<http://www.cbs.dtu.dk/services/LipoP>; Juncker et al., [@B19]), respectively. With these predictors, candidates were categorized into the cytoplasmic, membrane-associated (or surface exposed) and secreted proteins.

Gene ontology was then retrieved only for surface-exposed proteins using Blast2GO (<https://www.blast2go.com>), which provided annotations from characterized proteins, whereas for non-annotated proteins annotations were retrieved from their orthologs (\>95% identity). For proteins lacking annotations from Blast2GO, a search was performed in UniProt (<http://www.uniprot.org/>).

Synthesis of recombinant forms of the shortlisted proteins
----------------------------------------------------------

Shortlisted protein candidates were overexpressed in *E. coli*. In brief, gene fragments encoding surface exposed region of proteins were amplified by PCR from genomic DNA of N. meningitidis. Amino acid and nucleotide sequences of amplified regions are presented in Supplementary Data Sheet [1](#SM1){ref-type="supplementary-material"}. Detailed information on primer design, amplicon lengths and restriction enzymes used are presented in Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}. Digestion of amplified PCR products, ligation into a pQE-30-mCherry-GFP plasmid (in-house modified vector pQE-30 UA, Qiagen Comor et al., [@B4], transformation and selection of clones were performed as described earlier Jimenez-Munguia et al., [@B18]. Insertion of encoding genes was confirmed by sequencing with vector specific primers UA Insertom F and R (Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}). Protein expression and purification with metal affinity chromatography were also carried out as described previously (Jimenez-Munguia et al., [@B18]). The purity of recombinant proteins was assessed by SDS-PAGE, while molecular mass was measured by MALDI-TOF MS. Protein concentration was measured using Bradford assay and aliquots of purified proteins were stored at −20°C in 20% glycerol until use.

Confirmation of interaction between recombinant ligands of meningococci and proteins of hBMECs
----------------------------------------------------------------------------------------------

To confirm the interactions between recombinant ligands of meningococci and proteins of hBMECs an ELISA was performed as described previously (Jimenez-Munguia et al., [@B18]) with minor modifications. Briefly, wells were coated with protein extract of hBMECs diluted in coating buffer (8 μg of protein in 10 mM Na~2~CO~3~, 40 mM NaHCO~3~, pH 7.2). hBMECs proteins were incubated with various concentrations of each recombinant ligand (10, 20, or 40 μg/mL) for 1 h at room temperature. Bound recombinant proteins were detected with HisProbe-HRP (1 μg/mL dissolved in PBS containing 0.05% Tween-20, 30 min incubation at room temperature, Thermo Fisher Scientific). The reaction was developed with HRP substrate (LI-COR, Biosciences) and measured at 700 nm (Odyssey CLx, LI-COR Bioscience).

For input controls, 2 μg of each recombinant ligand were coated in the wells and detected with HisProbe-HRP. As negative controls, 8 μg of the cell extract of hBMECs were coated in the wells and incubated with HisProbe-HRP. As a positive control, 8 μg of the cell extract of hBMECs were incubated with domain III of protein E of West Nile Virus (known protein that interacts with hBMECs). The assay was performed in triplicates.

Confirmation of binding of ligands to the cultured hBMECs
---------------------------------------------------------

Immunocytochemistry was performed as described previously (Jimenez-Munguia et al., [@B18]) with minor modifications. In brief, hBMECs were cultured on the coverslips coated with collagen type I (Sigma, USA) until 70% confluency. Cells were incubated with purified recombinant ligands (25 μg resuspended in 2 mL EBM-2 medium) for 2 h at 37°C in 5% CO~2~. Cells were washed with PBS containing Tween 20 (0.05%, PBST), fixed with ethanol/acetone (2:8 v/v) for 10 min and washed again three times. Bound recombinant proteins were detected with anti-His antibody conjugated with FITC, whereas nuclei were stained with DAPI (Sigma).

As negative control assay was performed without recombinant ligands. Domain III of protein E of West Nile Virus was also included in the experiment as positive control. Imaging was performed using LSM-710 microscope (Zeiss, Germany). The assay was performed in biological triplicates.

Results {#s3}
=======

Identification of putative surface interactome of *N. meningitidis*
-------------------------------------------------------------------

Biotinylation of *N. meningitidis* proteome was evaluated by capturing labeled proteins on NeutrAvidin beads. We observed that most of the protein species were recovered when compared with the whole cell extract of *N. meningitidis* (Figure [2A](#F2){ref-type="fig"}). Recovery of the interacting biotinylated proteins in S2 eluate was evaluated with dot blot (Figure [2B](#F2){ref-type="fig"}). Further, with the SWATH-MS we succeeded in the identification of 84 proteins, which may bind to the endothelial cells (Supplementary Data Sheet [3](#SM3){ref-type="supplementary-material"}).

![Biotinylation of *N. meningitidis* proteome and confirmation of the presence of biotinylated proteins bound to hBMECs. **(A)** Lane 1--Protein extract of meningococci prior to biotinylation separated on SDS-PAGE. Lane 2--Biotinylated proteins were incubated with NeutrAvidin capture beads, eluted with 50 mM DTT and separated on SDS-PAGE. **(B)** Dot blot. S2--Protein extract of hBMECs obtained after incubation with biotinylated proteins of meningococci spotted on the membrane and detected with IRdye®;800 Streptavidin. Negative control--Total protein extract of hBMECs was spotted on the membrane and incubated with IRdye®;800 Streptavidin, Input control--Biotinylated proteins of meningococci were spotted on the membrane and detected with IRdye®;800 Streptavidin.](fmicb-09-02294-g0002){#F2}

Considering the importance of surface proteins in the crosstalk of pathogen and host cells, we used a systematic pipeline that combines series of bioinformatic tools and literature review to identify surface interactome of *N. meningitidis*. This pipeline was established to shortlist potential ligands by eliminating proteins with less chance to bind hBMECs (e.g., intracellular proteins) and segregating the surface proteins according to their probability to interact with host cells (e.g., outer membrane, inner membrane and secretory proteins). Out of 84 candidates identified by SWATH-MS, 43 proteins were predicted (Cello and Psortb algorithms) as cytoplasmic and were excluded from further analysis due to the low probability of their interaction with the host cells. The remaining 41 proteins were predicted as surface-exposed proteins and were considered as probable surface interactome against hBMECs (Figure [3](#F3){ref-type="fig"}). For a better selection of ligand candidates, surface interactome was further categorized (SignalP, LipoP, TMHMM, and HMMtop) into three groups according to the type of surface exposure (e.g., outer membrane, inner membrane and secretion). Surface exposure of ligand influences the probability of its contact with the receptor. Group 1. *high priority candidates*--consisted of 21 outer membrane proteins (including six lipoproteins), group 2. *medium priority candidates*--contained 14 inner membrane proteins (including three lipoproteins), and group 3. *low priority candidates*--contained six secretory proteins (Table [1](#T1){ref-type="table"}; Figure [3](#F3){ref-type="fig"}).

![Prediction of subcellular location of identified proteins of *N. meningitidis*. Proteins identified by SWATH-MS were subjected to *in silico* prediction of subcellular location. Psortb and CELLO segregated proteins into two categories (cytoplasmic and surface proteins). Surface proteins (interactome) were further classified into three categories based on their probability of interaction with the host cells: high (containing outer membrane), medium (inner membrane) and low priority candidates (secretory proteins), by applying bioinformatic tools to predict transmembrane domains (TMHMM and HMMtop) and type I and II signal peptides (SignalP and LipoP).](fmicb-09-02294-g0003){#F3}

###### 

Surface interactome of N. meningitidis against hBMECs identified in our study by SWATH-MS.

  **No**.                                                             **Entry**   **Protein name**                                                          **Locus**   **Psortb**       **Cello**                      **SignalP**   **LipoP**     **TMHMM**   **HMMTOP**   **Consensus**
  ------------------------------------------------------------------- ----------- ------------------------------------------------------------------------- ----------- ---------------- ------------------------------ ------------- ------------- ----------- ------------ -----------------------------
  **GROUP 1. HIGH PRIORITY CANDIDATES (OUTER MEMBRANE PROTEINS)**                                                                                                                                                                                                            
  1                                                                   Q7DDI3      Class 5 outer membrane protein                                            NMB1053     Inner membrane   Outer membrane                 Yes           SP1           Outside     Outside      Outer membrane
  2                                                                   Q9K187      LPS-assembly protein LptD                                                 NMB0280     Outer membrane   Outer membrane                 Yes           SP1           Outside     Outside      Outer membrane
  3                                                                   Q9JXN3      VacJ-related protein                                                      NMB1961     Outer membrane   Outer membrane                 Yes           SP1           Outside     Outside      Outer membrane
  4                                                                   Q9JXK7      Putative adhesin/invasion                                                 NMB1994     Outer membrane   Extracellular                  Yes           SP1           Outside     Outside      Outer membrane
  5                                                                   Q9JS44      Adhesin MafA1                                                             NMB0375     Unknown          Outer membrane                 No            SP2           Outside     Outside      Outer membrane
  6                                                                   Q7DDH4      Putative lipoprotein                                                      NMB1126     Unknown          Extracellular                  Yes           SP2           Outside     Outside      Outer membrane
  7                                                                   Q06379      Lactoferrin-binding protein A (Iron-regulated outer membrane protein A)   NMB1540     Outer membrane   Outer membrane                 Yes           SP1           Outside     1 TMD        Outer membrane
  8                                                                   P0DH58      Major outer membrane protein P.IA                                         NMB1429     Outer membrane   Outer membrane                 Yes           SP1           Outside     1 TMD        Outer membrane
  9                                                                   Q9K1M2      Putative outer membrane protein                                           NMB0088     Outer membrane   Outer membrane/Extracellular   Yes           SP1           Outside     1 TMD        Outer membrane
  10                                                                  P30690      Major outer membrane protein P.IB                                         NMB2039     Outer membrane   Outer membrane                 Yes           SP1           1 TMD       1 TMD        Outer membrane
  11                                                                  P57026      Outer membrane protein H.8                                                NMB1533     Outer membrane   Periplasmic                    Yes           SP2           Outside     Inside       Outer membrane
  12                                                                  Q9K0A7      LPS-assembly lipoprotein LptE                                             NMB0707     Unknown          Cytoplasmic                    No            SP2           Outside     Outside      Outer membrane
  13                                                                  Q9K0K8      Putative adhesin                                                          NMB0586     Outer membrane   Periplasmic                    Yes           SP1           Outside     1 TMD        Outer membrane
  14                                                                  Q9JXB7      Uncharacterized protein                                                   NMB2134     Outer membrane   Outer membrane                 No            SP1           1 TMD       1 TMD        Outer membrane
  15                                                                  Q9K0U9      Transferrin-binding protein 1                                             NMB0461     Outer membrane   Outer membrane                 Yes           SP1           Outside     Outside      Outer membrane
  16                                                                  Q9K0V0      Transferrin-binding protein 2 (TBP-2)                                     NMB0460     Unknown          Extracellular                  No            SP2           Outside     1 TMD        Outer membrane
  17                                                                  Q7DDB6      Probable TonB-dependent receptor                                          NMB1497     Outer membrane   Outer membrane                 No            SP1           Outside     Outside      Outer membrane
  18                                                                  Q7DDJ2      Adhesin                                                                   NMB0992     Unknown          Extracellular                  Yes           SP1           Outside     Outside      Outer membrane
  19                                                                  Q9JYP9      Putative lipoprotein NlpD                                                 NMB1483     Unknown          Periplasmic                    Yes           SP2           Outside     Outside      Outer membrane
  20                                                                  Q9JXL6      Adhesion and penetration protein                                          NMB1985     Outer membrane   Outer membrane                 No            SP1           1 TMD       1 TMD        Outer membrane
  21                                                                  Q9K165      TPR repeat-containing protein                                             NMB0313     Unknown          Outer membrane                 Yes           SP1           Outside     1 TMD        Outer membrane
  **GROUP 2. MEDIUM PRIORITY CANDIDATES (INNER MEMBRANE PROTEINS)**                                                                                                                                                                                                          
  22                                                                  Q9JXD8      Putative adhesin complex protein                                          NMB2095     Unknown          Periplasmic                    Yes           SP1           Outside     1 TMD        Inner membrane
  23                                                                  Q9JXT1      Lipoprotein                                                               NMB1898     Unknown          Periplasmic                    Yes           SP2           Outside     1 TMD        Inner membrane
  24                                                                  Q9JYG9      Putative lipoprotein                                                      NMB1592     Unknown          Periplasmic                    No            SP2           Outside     1 TMD        Inner membrane
  25                                                                  Q9K0S2      Uncharacterized protein                                                   NMB0506     Unknown          Outer membrane/Periplasmic     Yes           SP1           1 TMD       1 TMD        Inner membrane
  26                                                                  Q9JZN1      Uncharacterized protein                                                   NMB0979     Inner membrane   Periplasmic/Inner membrane     Yes           SP1           1 TMD       1 TMD        Inner membrane
  27                                                                  Q9JZR5      Uncharacterized protein                                                   NMB0928     Inner membrane   Periplasmic                    No            Cytoplasmic   Outside     1 TMD        Inner membrane
  28                                                                  Q9JS13      Uncharacterized protein                                                   NMB1147     Cytoplasmic      Periplasmic/Cytoplasmic        No            Cytoplasmic   1 TMD       1 TMD        Inner membrane
  29                                                                  Q9JY47      Uncharacterized protein                                                   NMB1749     Unknown          Periplasmic                    No            Cytoplasmic   1 TMD       1 TMD        Inner membrane
  30                                                                  Q9K1L2      Uncharacterized protein                                                   NMB0102     Inner membrane   Inner membrane                 No            Cytoplasmic   1 TMD       1 TMD        Inner membrane
  31                                                                  Q9K173      ComEA-related protein                                                     NMB0299     Inner membrane   Periplasmic                    No            TMD           1 TMD       1 TMD        Inner membrane
  32                                                                  Q9JXG2      Uncharacterized protein                                                   NMB2064     Inner membrane   Inner membrane                 No            TMD           1 TMD       1 TMD        Inner membrane
  33                                                                  Q7DDI4      DedA protein                                                              NMB1052     Unknown          Inner membrane                 No            TMD           \>1 TMD     \>1 TMD      Inner membrane
  34                                                                  Q7DDC1      Uncharacterized protein                                                   NMB1397     Inner membrane   Cytoplasmic                    No            TMD           1 TMD       1 TMD        Inner membrane
  35                                                                  Q7DD63      Outer membrane lipoprotein                                                NMB1946     Inner membrane   Periplasmic                    Yes           SP2           Outside     Outside      Inner membrane
  **GROUP 3. LOW PRIORITY CANDIDATES (SECRETORY PROTEINS)**                                                                                                                                                                                                                  
  36                                                                  Q9JYV5      Iron-regulated protein FrpC                                               NMB1415     Extracellular    Extracellular/                 No            Cytoplasmic   Outside     Outside      Secretory protein
  37                                                                  Q9K0T0      Hemagglutinin/hemolysin-related protein                                   NMB0493     Outer membrane   Extracellular                  No            Cytoplasmic   Outside     Outside      Secretory protein secretory
  38                                                                  Q9JY23      Hemagglutinin/hemolysin-related protein                                   NMB1779     Outer membrane   Extracellular                  No            SP1           Outside     Outside      Secretory protein
  39                                                                  Q9JYW0      FrpA/C-related protein                                                    NMB1409     Unknown          Outer membrane                 No            Cytoplasmic   Outside     Outside      Secretory protein
  40                                                                  Q9K0K9      Iron-regulated protein FrpA                                               NMB0585     Extracellular    Extracellular                  No            Cytoplasmic   Outside     Outside      Secretory protein
  41                                                                  Q9JZ25      Uncharacterized protein                                                   NMB1327     Extracellular    Periplasmic                    No            Cytoplasmic   Outside     Outside      Secretory protein

*Categories for the subcellular location were established according to Psortb and Cello. SignalP and LipoP discriminate proteins containing a SP-I type and SP-II type signal peptides, respectively; and proteins containing transmembrane domains (TMD) were predicted by TMHMM and HMMTOP*.

*In silico* analysis of the *N. meningitidis* surface interactome
-----------------------------------------------------------------

The Blast2GO analysis applied to obtain gene ontology annotations showed that 58.6% of proteins (24 out of 41 candidates) or their orthologs are not annotated (neither in UniProt). Among annotated candidates, majority were related to transport (7 out of 41 proteins, included in group 1; Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}). Five proteins (NMB0280, NMB1497, NMB0461, NMB1126, and NMB1429) out of those seven were annotated as transport proteins, while two proteins are also involved in other functions, such as signal transduction and response to the stress (NMB2039) or cell adhesion and ion binding (NMB0586). A role in cell adhesion was also annotated to adhesin MafA1 protein (NMB0375). Four proteins from group 1 participate in ion binding, namely NMB0586, NMB0585, NMB1533 and the class 5 outer membrane protein NMB1053. The class 5 outer membrane protein and NMB1985 also possesses peptidase activity. Gene ontology terms related to the membrane organization, cellular component assembly, DNA binding, etc. were grouped into the category "miscellaneous" (Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}). Two proteins (NMB0707 and NMB1483) from group 1 and three proteins (NMB0299, NMB2095, and NMB1946) from group 2 belonged to this category.

As the Blast2GO failed to provide any relevant information for 24 non-annotated proteins, the literature review was performed. Information for four candidates was retrieved. Transferrin-binding protein 2 (NMB0460) and lactoferrin binding protein A (NMB1540) are associated with transport and ion binding, whereas Iron--regulated protein FrpC (NMB1415) and FrpA/C related protein (NMB1409) are reported as ion binding proteins (Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}).

Selection of protein candidates for validation of interaction with hBMECs
-------------------------------------------------------------------------

Following the bioinformatic pipeline, we selected five proteins for the production of their recombinant forms and subsequent validation of interaction with hBMECs. Four proteins were chosen from group 1 (outer membrane proteins) as follows: MafA1 (NMB0375) was selected as its role in adhesion of *N. gonorrhoeae* to the epithelial cells was described in the literature, however, its function in *N. meningitidis* is not studied yet. Similarly, a major outer membrane protein P.IB (NMB2039) is functionally characterized only in *N. gonorrhoeae*. The third candidate, putative adhesin/invasion (neisserial adhesin A-NadA, NMB1994) also possesses affinity to epithelial cells, while the fourth selected candidate (putative lipoprotein-NMB1126) is from lipoprotein family. The fifth protein (membrane lipoprotein, NMB1946) was predicted as an inner membrane protein (group 2) with bioinformatic tools used in this study, however, in the UniProt database it is annotated as an outer membrane protein and is one of possible vaccine candidate (**Table 3** in Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}).

Validation of protein-protein interactions and ligand-hBMECs interaction
------------------------------------------------------------------------

To confirm the interaction between shortlisted ligands and proteins of hBMECs, we produced recombinant forms of ligands (Table [2](#T2){ref-type="table"}). Correct insertion of the gene of interest in the transformants, the purity of the recombinant proteins evaluated by SDS-PAGE and molecular masses assessed by MALDI-TOF are shown in Figure [4](#F4){ref-type="fig"}. The interaction between recombinant ligands and proteins of hBMECs was evaluated by ELISA (Figure [5A](#F5){ref-type="fig"}). Of note, control experiment without recombinant proteins (negative control, also used for background subtraction, Relative Fluorescence Unit RFU-0.073) confirmed the specificity of the assay. When recombinant ligands were used at 20 μg/mL, binding of putative lipoprotein NMB1126 was the strongest (RFU-2213.3, SD-331.3) followed by putative adhesin/invasion protein NMB1994 (RFU-1776.7, SD-275.4) and NMB2039 major outer membrane protein P.IB (RFU-1175, SD-190.9; Figure [5A](#F5){ref-type="fig"}). Dose-dependent interaction between hBMECs and recombinant ligands was also assessed, wherein we found that recombinant NMB2039, NMB1994, and NMB1126 were also able to interact with hBMECs at lower concentration (10 μg/mL; Figure [5A](#F5){ref-type="fig"}). The binding of NMB1946 to hBMECs at 20 μg/mL was the lowest (RFU-235 SD-11.1), however, at 40 μg/mL it appears to bind hBMECs on the same level as other proteins (Figure [5A](#F5){ref-type="fig"}). RFU for control experiment with domain III of protein E of West Nile virus (positive control) was 1,673.5 with standard deviation 798.8.

###### 

Potential ligands of *N. meningitidis* selected to produce their recombinant form.

  **No**.   **Entry UniProt**   **Protein name**                    **Locus**   **Amino acids position in recombinant form**   **Mr (kDa)**   
  --------- ------------------- ----------------------------------- ----------- ---------------------------------------------- -------------- -----
  1         Q9JS44              Adhesin MafA1                       NMB0375     G30--I307                                      59.3           ≈59
  2         P30690              Major outer membrane protein P.IB   NMB2039     A19--F331                                      62.3           ≈60
  3         Q9JXK7              Putative adhesin/invasion (NadA)    NMB1994     A135--I328                                     57.9           ≈60
  4         Q7DDH4              Putative lipoprotein                NMB1126     E23--G217                                      48.0           ≈49
  5         Q7DD63              Outer membrane lipoprotein          NMB1946     Q23--K287                                      56.0           ≈57

![Production of recombinant forms of the selected protein candidates. **(A)** Amplicons of the five gene coding fragments of potential ligands of meningococci resolved on the agarose gel; **(B)** purified recombinant proteins separated with SDS-PAGE; **(C)** molecular mass of recombinant proteins confirmed with MALDI-TOF/MS. Lane 1, adhesin MafA1 (NMB0375); Lane 2, major outer membrane protein P.IB (NMB2039); Lane 3, putative adhesin/invasion (NMB1994); Lane 4, putative lipoprotein (NMB1126); and Lane 5, outer membrane lipoprotein (NMB1946).](fmicb-09-02294-g0004){#F4}

![Validation of interaction between selected protein candidates of *N. meningitidis* and cell lysate of hBMECs by semi-quantitative ELISA and immunocytochemistry. **(A)** Semi-quantitative ELISA performed to confirm the interaction between proteins of hBMECs and bacterial ligands (different concentrations). The interaction was detected with HisProbe conjugated with HRP and is shown in Relative Fluorescence Units (RFU). As positive control (+ control)--domain III protein E of West Nile virus was used. Negative control: (-- control)--no ligand was added. Input control: recombinant ligand NMB0375 was coated and incubated with HisProbe-HRP and substrate. **(B)** Interaction of selected proteins of *N. meningitidis* with cultured hBMECs. Nuclei are stained with DAPI. Negative control--no recombinant ligand was included in the assay. Scale bars−10 μm. In both panels: NMB0375-adhesin MafA1; NMB2039-major outer membrane protein P.IB; NMB1994-putative adhesin/invasion; NMB1126-putative lipoprotein; NMB1946-outer membrane lipoprotein. Assays were performed in triplicate.](fmicb-09-02294-g0005){#F5}

We also performed immunocytochemistry to corroborate the interaction between meningococcal ligands and hBMECs. The binding of NMB0375 adhesin MafA and NMB1994 putative adhesin/invasion on endothelial cells was evidently stronger than other three meningococcal ligands (Figure [5B](#F5){ref-type="fig"}). The binding of domain III of protein E of West Nile virus on endothelial cells was in correlation with its affinity observed in ELISA (Figures [5A,B](#F5){ref-type="fig"}).

Discussion {#s4}
==========

Microbial traversal of the BBB is a prerequisite for CNS infections. Pathogen invading CNS can traverse through the BBB using paracellular or transcellular routes. Initiation of bacterial translocation, via paracellular and transcellular pathways, occurs through the interactions of surface proteins of pathogen and the BBB (Pulzova et al., [@B36]). These protein-protein interactions (PPIs) provide valuable insight into the molecular networks that unfolds basic principles of pathogen invasion (Nicod et al., [@B29]). In this study, we attempted to identify the surface interactome of *N. meningitidis* plausibly interacting with hBMECs using high-throughput proteomic methods followed by an integrative bioinformatic analysis. Data from the available scientific publications were brought to draw appropriate interpretations.

Initially, we attempted to label surface proteome of the intact bacterial cells and extract biotin-labeled proteome. However, the labeling efficiency was low and few protein species were recovered (data are not shown). We speculate that capsule present on *N. meningitidis*, hinders labeling of the surface proteins with biotin. Thus, the whole proteome of meningococcus was biotinylated. As a result, it was possible to recover majority of meningococcal proteins that were used to identify interacting candidates with hBMECs (Figure [2A](#F2){ref-type="fig"}). Biotinylation of the whole cell proteomes or cell surface proteins has been performed in recent proteomic studies (Kay et al., [@B20]; Hormann et al., [@B14]; Jimenez-Munguia et al., [@B18]).

High-throughput approach to identify surface proteins of bacterial pathogens has been well-documented (Vytvytska et al., [@B48]; Jimenez-Munguia et al., [@B18]). Among the various mass spectrometry based methods, data-independent acquisition (SWATH-MS) technique is highly sensitive and robust method to accurately identify peptides (Ortea et al., [@B30]). Due to the high sensitivity of SWATH-MS even the minor interactors (or low abundant proteins) were possible to detect.

In many cases, high-throughput approaches generate a number of probable interactors, from which it is necessary to filter false positive hits. Thus, we have proposed a bioinformatic pipeline to specifically select proteins based on their highest probability of interaction with hBMECs. The implied method of exploiting multiple combinations of freely available bioinformatic tools is noteworthy.

Membrane proteins of Gram-negative bacteria predominantly consist of large, hydrophobic, antiparallel β-barrels that are localized into the membrane with the polar segments protruding at the extracellular region (Jeanteur et al., [@B16]; von Heijne, [@B47]). Therefore, it is difficult to resolve these proteins on 2D-PAGE. Applying SWATH-MS we were able to identify 84 proteins. Protein candidates were selected based on their subcellular location through the bioinformatic pipeline described in this work. As the surface exposed proteins are important in the initial stages of paracellular or transcellular pathways, cytoplasmic proteins were excluded from further analysis. The exclusion is also supported in other studies (Krumins and Stotzky, [@B23]; Maurel et al., [@B25]; Jimenez-Munguia et al., [@B18]). Apart from the surface proteins, 43 cytoplasmic proteins were identified that may bind with hBMECs directly or through other surface proteins (Rankl et al., [@B37]; Jeyachandran et al., [@B17]).

Thirty-five proteins were predicted as surface-associated in this study (plausible surface interactome). As far as the probability of interaction to the hBMECs is concerned, class 5 outer membrane proteins, ion binding proteins, adhesins and proteins from lipoprotein family are promising candidates in the surface interactome obtained in this study. Opc (NMB1053), a class 5 outer membrane protein was observed in the interactome. Class 5 proteins (e.g., Opc and Opa) and type IV pili (Tfp) enables adhesion of meningococci to the human cells (Virji et al., [@B44]; Virji, [@B43]). Earlier it was though that Opc and Opa are hidden under the polysaccharide capsule and are thus inaccessible to their receptors. However, it was later shown that expression of the capsule is diminished during meningococcal infection to allow interaction of surface ligands including Opa and Opc proteins with human cells (Virji et al., [@B45], [@B44]; Dehio et al., [@B8]). Opa recognizes the members of CEACAM (carcinoembryonic antigen-related cell adhesion molecule) proteins on host cells (Virji et al., [@B46]), whereas Opc was shown to bind to HSPGs (heparan sulfate proteoglycans), and thus both proteins mediate adhesion and invasion of epithelial cells (de Vries et al., [@B7]). Although, Pili, Opc and Opa are abundant proteins on the neisserial surface (also referred as major adhesins), other surface proteins expressed in low amount (minor adhesins) might also play a crucial role in the bacterial adhesion and cell invasion. Role of minor adhesins in pathogenesis is predicted earlier (Hill et al., [@B13]). In this study, we have identified NMB1994-putative adhesin/invasion protein, NMB0586-putative adhesin, NMB2095-putative adhesin complex protein, NMB1985-adhesion/penetration protein and NMB0992-adhesin that may be designated as minor adhesins.

Proteins belonging to the lipoprotein family (e.g., components of the type IV pili) are important virulence factors of *N. meningitidis* as described in Kovacs-Simon et al (Kovacs-Simon et al., [@B21]). Lipoproteins are also attractive vaccine candidates, either in recombinant forms or in novel outer membrane vesicles (OMV) based vaccines. Putative lipoprotein (NMB1126), adhesin MafA1 (NMB0375), LPS-assembly lipoprotein LptE (NMB0707), outer membrane protein H.8 (NMB1533), putative lipoprotein NlpD (NMB1483) and lipoprotein (NMB1898) were among the identified candidates with lipid moiety in our study. Ion binding proteins are another group of proteins, considered as an important pathogenicity factor for meningococcal disease (Cornelissen and Sparling, [@B6]; Cornelissen, [@B5]). In the repertoire of surface interactome we found several ion binding candidates *viz*. transferrin-binding proteins Tbp1 NMB0461 and Tbp2 NMB0460 (mediating iron acquisition in the host), iron-regulated protein FrpA (NMB1409), iron-regulated protein FrpC (NMB1415), lactoferrin-binding protein A (NMB1540) and transferrin-binding protein 1 (NMB046; Table [1](#T1){ref-type="table"}). Lactoferrin-binding protein A (LbpA) participates in recruitment of lactoferrin and is an important virulence factor of the meningococci (Pettersson et al., [@B33]). It is noteworthy that, lactoferrin is able to cross the BBB during an acute phase of inflammation and serves as a resource of iron during the invasion (Huettinger et al., [@B15]; Pettersson et al., [@B34]). This underlines the importance of LbpA in the process of neuroinvasion.

After segregation of protein candidates according to their subcellular location, bioinformatic pipeline described in this study was applied to collect relevant biological data for each shortlisted protein. Blast2GO provided gene ontology annotations for 17 protein interactors. The GO analysis has assigned cell adhesion, transport and ion binding functions for putative adhesin (NMB0586). Another putative adhesin/invasion protein (NMB1994), had 100% similarity with neisserial adhesin A (NadA), which has been reported to interact with epithelial cells (Capecchi et al., [@B3]). Interaction of NadA with hBMECs confirmed in this study (Figure [5](#F5){ref-type="fig"}) further adds to its significance in pathogenicity of *N. meningitidis*. Unfortunately, Blast2GO failed to retrieve annotations for 41.4% proteins, while literature review (Supplementary Data Sheet [2](#SM2){ref-type="supplementary-material"}) provided information only on four non-annotated proteins \[NMB0460, NMB1540, NMB1415 and NMB1409 that are associated with ion binding (Thompson and Sparling, [@B40]; Thompson et al., [@B41])\]. These non-annotated proteins needs further exploration to determine their biological function in pathogenesis.

Among five potential ligands selected for validation of interaction with hBMECs four proteins (NMB0375, NMB2039, NMB1994, and NMB1126) were selected from outer membrane proteins (group 1) because their surface exposure may facilitate contact and interaction with hBMECs. Relatively less is known about MafA1 (NMB0375) in *N. meningitidis*, however, it is reported that MafA1 of *N. gonorrhoeae* interacts with gangliotriosylceramide (GgO~3~) and gangliotetraosylceramide (GgO~4~) expressed on human endocervical cells (Paruchuri et al., [@B31]). Major outer membrane protein P.IB (NMB2039), another selected candidate belongs to the group of porins, abundantly localized on the outer membrane of pathogenic *Neisseria* (Wetzler, [@B49]). The interaction of P.IB protein with hBMECs and its subsequent effect on cell signaling has not yet been reviewed. However, it was found that P.IB of *N. gonorrhoeae* (PorB~IA~) binds to the scavenger receptor on endothelial cells (SREC-I), which leads to the bacterial uptake into endothelial or epithelial cells (Rechner et al., [@B38]). It is plausible that P.IB of *N. meningitidis* identified in the present study could bind to SREC-I of hBMECs. Third selected candidate, putative adhesin/invasion (neisserial adhesin A-NadA, NMB1994) is described to interact strongly with epithelial cells (Capecchi et al., [@B3]) but not with hBMECs. The fourth candidate selected for validation was the putative lipoprotein (NMB1126), a member of the lipoprotein family. NMB1946 (the fifth selected candidate) was reported to be a potential vaccine candidate against N. *meningitidis* (Pizza et al., [@B35]; Neumoin et al., [@B28]). NMB1946 and its homolog in N. *gonorrhoeae* were found upregulated in the presence of blood and a knockout mutant was found to be less competitive than the wild type strain (Echenique-Rivera et al., [@B10]). Interaction of above mentioned proteins with hBMECs was validated with both ELISA and immunocytochemistry (Figure [5](#F5){ref-type="fig"}).

To conclude, the proposed workflow is suitable for high-throughput screening of interacting proteins. This approach allowed us to identify interactome of the *N. meningitidis* against hBMECs for the selection of potential ligands. Furthermore, we have experimentally confirmed the interaction of five recombinant ligands with hBMECs. This systematic combination of proteomics and bioinformatic tools can potentially be applied to different microorganisms in deciphering their interactome at varying environmental conditions.
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